Why then is it being formulated to powder? Why go to the expense and time of doing it? It is not necessarily the next step. If there had not been palatability issues I dare say the company would not have made any changes to the form in which mpl was administered at all. But I take your point that palatability was not mentioned in the relevant paragraph of the report.
Why then is it being formulated to powder? Why go to the expense...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.26M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $30.05K | 169.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 40858 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 251838 | 4 |
View Market Depth
| Last trade - 16.10pm 23/05/2024 (20 minute delay) ? |
|
|||||
|
Last
17.5¢ |
Change
0.000 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 18.0¢ | 17.5¢ | 95663 | ||
| Last updated 15.08pm 23/05/2024 ? | |||||
| PAA (ASX) Chart |